semaglutide cagrilintide dosage ghk-cu mg Once-weekly for weight management in people with overweight and obesity: a multicentre, randomised, double-blind, placebo-controlled and active-controlled, dose-finding phase 2 trial cagrilintide dosage chart cagrilintide semaglutide dosage chart Efficacy

No dry ice

Even so, the trial design was rigorous, and the findings are consistent with what clinicians have observed in practice

Dose Comparison for Different Goals Maximum Weight Loss Dose: 8-12 mg weekly Rationale: Strongest appetite suppression and metabolic effects Body Recomposition Dose: 4-8 mg weekly Rationale: Balance of metabolic benefits with manageable appetite Lean Bulking Dose: 2-4 mg weekly Rationale: Metabolic support with minimal appetite interference Maintenance Dose: 2-4 mg weekly Rationale: Sustain improvements with low side effect burden Lower doses in the 2-4 mg range provide meaningful metabolic benefits including improved insulin sensitivity, enhanced fat oxidation, and better nutrient partitioning without the profound appetite suppression that makes eating adequate calories difficult

Whether this partnership model becomes a broader industry template remains to be seen, but it signals that the path forward for telehealth companies in the GLP-1 space will increasingly run through collaboration with branded manufacturers rather than competition via compounded alternatives